Antibody-drug conjugates gain traction in China oncology market: GlobalData EP News Bureau Apr 4, 2023 The diagnosed prevalent cases of gastric, breast, and bladder cancers in China are expected to increase at a CAGR of 2.6 per cent,…
Tel Aviv University develops novel lipid nanoparticle-based delivery system to destroy cancer cells EP News Bureau Jan 4, 2021 The system, called CRISPR-LNPs, carries a genetic messenger (messenger RNA), which encodes for the CRISPR enzyme Cas9 that acts as…
GSK gets USFDA approval for BLENREP to treat relapsed or refractory multiple myeloma EP News Bureau Aug 6, 2020 BLENREP is the fifth major medicine approval for GSK in 2020
